
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with ...
SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in …